Loading...
Immunomodulatory, Liver Depot Gene Therapy for Pompe Disease
Pompe disease is caused by mutations in acid alpha glucosidase (GAA) that causes accumulation of lysosomal glycogen affecting the heart and skeletal muscles, and can be fatal. Enzyme replacement therapy (ERT) with recombinant human GAA (rhGAA) improves muscle function by reducing glycogen accumulati...
Na minha lista:
| Udgivet i: | Cell Immunol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6026080/ https://ncbi.nlm.nih.gov/pubmed/29295737 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cellimm.2017.12.011 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|